Chapman KR - Search Results

1

Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.

Wedzicha JA, Banerji D, Chapman KR, Vestbo J, Roche N, Ayers RT, Thach C, Fogel R, Patalano F, Vogelmeier CF; FLAME Investigators. Wedzicha JA, et al. Among authors: chapman kr. N Engl J Med. 2016 Jun 9;374(23):2222-34. doi: 10.1056/NEJMoa1516385. Epub 2016 May 15. N Engl J Med. 2016. PMID: 27181606 Free article. Clinical Trial.

2

Effect of a short course of prednisone in the prevention of early relapse after the emergency room treatment of acute asthma.

Chapman KR, Verbeek PR, White JG, Rebuck AS. Chapman KR, et al. N Engl J Med. 1991 Mar 21;324(12):788-94. doi: 10.1056/NEJM199103213241202. N Engl J Med. 1991. PMID: 1997850 Free article. Clinical Trial.

3

Effectiveness and safety of salmeterol in nonspecialist practice settings.

D'Urzo AD, Chapman KR, Cartier A, Hargreave FE, Fitzgerald M, Tesarowski D. D'Urzo AD, et al. Among authors: chapman kr. Chest. 2001 Mar;119(3):714-9. doi: 10.1378/chest.119.3.714. Chest. 2001. PMID: 11243947 Clinical Trial.

4

Seretide: a pharmacoeconomic analysis.

Fritscher L, Chapman KR. Fritscher L, et al. Among authors: chapman kr. J Med Econ. 2008;11(3):555-70. doi: 10.3111/13696990802320908. J Med Econ. 2008. PMID: 19450105 Review.

5

Long-term safety and efficacy of indacaterol, a long-acting β₂-agonist, in subjects with COPD: a randomized, placebo-controlled study.

Chapman KR, Rennard SI, Dogra A, Owen R, Lassen C, Kramer B; INDORSE Study Investigators. Chapman KR, et al. Chest. 2011 Jul;140(1):68-75. doi: 10.1378/chest.10-1830. Epub 2011 Feb 24. Chest. 2011. PMID: 21349928 Clinical Trial.

6

Comparative efficacy of indacaterol in chronic obstructive pulmonary disease.

Ribeiro M, Chapman KR. Ribeiro M, et al. Among authors: chapman kr. Int J Chron Obstruct Pulmon Dis. 2012;7:145-52. doi: 10.2147/COPD.S19805. Epub 2012 Mar 5. Int J Chron Obstruct Pulmon Dis. 2012. PMID: 22419862 Free PMC article. Review.

7

Safety and efficacy of dual bronchodilation with QVA149 in COPD patients: the ENLIGHTEN study.

Dahl R, Chapman KR, Rudolf M, Mehta R, Kho P, Alagappan VK, Chen H, Banerji D. Dahl R, et al. Among authors: chapman kr. Respir Med. 2013 Oct;107(10):1558-67. doi: 10.1016/j.rmed.2013.05.016. Epub 2013 Jul 16. Respir Med. 2013. PMID: 23867808 Free article. Clinical Trial.

8

Minimal clinically important differences in pharmacological trials.

Jones PW, Beeh KM, Chapman KR, Decramer M, Mahler DA, Wedzicha JA. Jones PW, et al. Among authors: chapman kr. Am J Respir Crit Care Med. 2014 Feb 1;189(3):250-5. doi: 10.1164/rccm.201310-1863PP. Am J Respir Crit Care Med. 2014. PMID: 24383418 Review.

9

A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study.

Chapman KR, Beeh KM, Beier J, Bateman ED, D'Urzo A, Nutbrown R, Henley M, Chen H, Overend T, D'Andrea P. Chapman KR, et al. BMC Pulm Med. 2014 Jan 17;14:4. doi: 10.1186/1471-2466-14-4. BMC Pulm Med. 2014. PMID: 24438744 Free PMC article. Clinical Trial.

10

Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study.

Decramer ML, Chapman KR, Dahl R, Frith P, Devouassoux G, Fritscher C, Cameron R, Shoaib M, Lawrence D, Young D, McBryan D; INVIGORATE investigators. Decramer ML, et al. Among authors: chapman kr. Lancet Respir Med. 2013 Sep;1(7):524-33. doi: 10.1016/S2213-2600(13)70158-9. Epub 2013 Aug 21. Lancet Respir Med. 2013. PMID: 24461613 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

338 results

Search Page